A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

NCT01028911 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped This study terminated 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.

Conditions

Interventions

Sponsor

Pfizer